These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25348062)

  • 1. A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy.
    López AG; Seoane JM; Sanjuán MA
    Bull Math Biol; 2014 Nov; 76(11):2884-906. PubMed ID: 25348062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Augmentation of antitumor immunity in cancer chemotherapy].
    Hosokawa M; Kobayashi H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1402-6. PubMed ID: 1697151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gompertz model with delays and treatment: mathematical analysis.
    Bodnar M; Piotrowska MJ; Foryś U
    Math Biosci Eng; 2013 Jun; 10(3):551-63. PubMed ID: 23906135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy.
    Schättler H; Ledzewicz U; Amini B
    J Math Biol; 2016 Apr; 72(5):1255-80. PubMed ID: 26089097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A validated mathematical model of cell-mediated immune response to tumor growth.
    de Pillis LG; Radunskaya AE; Wiseman CL
    Cancer Res; 2005 Sep; 65(17):7950-8. PubMed ID: 16140967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V alpha 24+ NKT cell-mediated cytotoxicity.
    Mattarollo SR; Kenna T; Nieda M; Nicol AJ
    Int J Cancer; 2006 Oct; 119(7):1630-7. PubMed ID: 16646079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls.
    de Pillis LG; Gu W; Fister KR; Head T; Maples K; Murugan A; Neal T; Yoshida K
    Math Biosci; 2007 Sep; 209(1):292-315. PubMed ID: 17306310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on: A validated mathematical model of cell-mediated immune response to tumor growth.
    Gowal S; de Giacomi M; Le Boudec JY
    Cancer Res; 2007 Sep; 67(17):8419-21; author reply 8420-1. PubMed ID: 17804759
    [No Abstract]   [Full Text] [Related]  

  • 9. A cellular automata model of tumor-immune system interactions.
    Mallet DG; De Pillis LG
    J Theor Biol; 2006 Apr; 239(3):334-50. PubMed ID: 16169016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model for tumour growth with treatment by continuous and pulsed chemotherapy.
    Borges FS; Iarosz KC; Ren HP; Batista AM; Baptista MS; Viana RL; Lopes SR; Grebogi C
    Biosystems; 2014 Feb; 116():43-8. PubMed ID: 24333154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoiding healthy cells extinction in a cancer model.
    López ÁG; Sabuco J; Seoane JM; Duarte J; Januário C; Sanjuán MA
    J Theor Biol; 2014 May; 349():74-81. PubMed ID: 24512918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On optimal chemotherapy with a strongly targeted agent for a model of tumor-immune system interactions with generalized logistic growth.
    Ledzewicz U; Olumoye O; Schättler H
    Math Biosci Eng; 2013 Jun; 10(3):787-802. PubMed ID: 23906150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model.
    Chen JH; Kuo YH; Luh HP
    Math Biosci; 2013 Oct; 245(2):282-98. PubMed ID: 23927854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of the acquired immune system in successful cancer chemotherapy with cis-diamminedichloroplatinum (II) in a syngeneic mouse tumor transplantation model.
    Taniguchi K; Nishiura H; Yamamoto T
    J Immunother; 2011; 34(6):480-9. PubMed ID: 21654518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delay equations modeling the effects of phase-specific drugs and immunotherapy on proliferating tumor cells.
    Barbarossa MV; Kuttler C; Zinsl J
    Math Biosci Eng; 2012 Apr; 9(2):241-57. PubMed ID: 22901063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between the immune system and cancer: a brief review of non-spatial mathematical models.
    Eftimie R; Bramson JL; Earn DJ
    Bull Math Biol; 2011 Jan; 73(1):2-32. PubMed ID: 20225137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of cellular immune response by Ipomoea obscura and Ipobscurine alkaloid attenuates tumor growth in mice.
    Hamsa TP; Kuttan G
    Can J Physiol Pharmacol; 2011 Apr; 89(4):259-68. PubMed ID: 21539469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
    Braster R; O'Toole T; van Egmond M
    Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated mechanisms influencing the efficacy of anticancer therapies.
    Coffelt SB; de Visser KE
    Trends Immunol; 2015 Apr; 36(4):198-216. PubMed ID: 25857662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 augments antitumor responses to cycled chemotherapy.
    Zhang L; Feng D; Hu Y; Tsung K; Norton JA
    J Immunother; 2015 May; 38(4):137-44. PubMed ID: 25839439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.